Jiya Acquisition Corp. (NASDAQ:JYAC) announced this afternoon that it will liquidate its trust due to its inability to complete a business combination.
The SPAC expects its shares to stop trading as of the close of business on November 23. As of November 25, the shares will be deemed cancelled and will represent only the right to receive the redemption amount.
JYAC marks the second liquidation of the day thus far, following Population Health (NASDAQ:PHIC). Both SPACs IPO’d on the same day, November 19, 2020, but PHIC, domiciled in the Cayman Islands, anticipates a redemption amount of $10.09 per share while JYAC, which was domiciled in Delaware, expects a redemption amount of just $10.05 per share.
Jiya raised $103.5 million in gross proceeds at its IPO and intended to combine with a biopharmaceutical target. The SPAC was led by Chairman Srinivas Akkaraju, CEO and Director Rekha Hemrajani, CFO, Secretary and CFO Richard Van Doren as well as Chief Investment Officer and Director Cory Freedland.
Prime Impact I (NYSE:PIAI) has entered into a definitive agreement to combine with auto insurance firm Cheche at an enterprise value of $841 million, or about 2.3x its 2022 revenue. Beijing-based Cheche provides a digital insurance platform for car owners in China with about 34 million vehicles covered. The combined company is expected to trade...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Hambro Perks eyes merger with Biotech Istesso, Rocket Lab launches first vehicle from U.S. soil, and Alliance Entertainment signs licensing agreement with The Walt Disney Company Hambro Perks SPAC Eyes Merger With Biotech...
Pono Capital Corp. (NASDAQ:PONO) disclosed in an 8-K filing this morning that its shareholders approved its combination with air mobility company AERWINS at a special meeting held on Friday, January 27. Holders of 12,412,861 common shares were present at the meeting and the deal was approved with 11,218,712 shares in favor of the transaction. The filing did not...
European Biotech (NASDAQ:EBAC) announced in an 8-K this morning that it has increased its PIPE by $7.8 million and added $7 million to the convertible loans attached to the combination with biotech firm Oculis. The new PIPE cash comes at $10 per share and joins $63.3 million in existing PIPE financing for a total of...
DHC Acquisition Corp (NASDAQ:DHCA) announced that it is formally terminating its combination with conservative banking venture GloriFi. This was essentially a formality because the SPAC already announced in November that GloriFi had begun the process of winding down. The two sides announced their $1.7 billion combination in July. But, even at the time, public details...